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Abstract
Background: New terminology continuously enters the biomedical literature. How can curators identify new terms
that can be added to existing nomenclatures? The most direct method, and one that has served well, involves reading
the current literature. The scholarly curator adds new terms as they are encountered. Present-day scholars are severely
challenged by the enormous volume of biomedical literature. Curators of medical nomenclatures need computational
assistance if they hope to keep their terminologies current. The purpose of this paper is to describe a method of rapidly
extracting new, candidate terms from huge volumes of biomedical text. The resulting lists of terms can be quickly
reviewed by curators and added to nomenclatures, if appropriate. The candidate term extractor uses a variation of the
previously described doublet coding method. The algorithm, which operates on virtually any nomenclature, derives from
the observation that most terms within a knowledge domain are composed entirely of word combinations found in other
terms from the same knowledge domain. Terms can be expressed as sequences of overlapping word doublets that have
more specific meaning than the individual words that compose the term. The algorithm parses through text, finding
contiguous sequences of word doublets that are known to occur somewhere in the reference nomenclature. When a
sequence of matching word doublets is encountered, it is compared with whole terms already included in the
nomenclature. If the doublet sequence is not already in the nomenclature, it is extracted as a candidate new term.
Candidate new terms can be reviewed by a curator to determine if they should be added to the nomenclature. An
implementation of the algorithm is demonstrated, using a corpus of published abstracts obtained through the National
Library of Medicine's PubMed query service and using "The developmental lineage classification and taxonomy of
neoplasms" as a reference nomenclature.
Results: A 31+ Megabyte corpus of pathology journal abstracts was parsed using the doublet extraction method. This
corpus consisted of 4,289 records, each containing an abstract title. The total number of words included in the abstract
titles was 50,547. New candidate terms for the nomenclature were automatically extracted from the titles of abstracts
in the corpus. Total execution time on a desktop computer with CPU speed of 2.79 GHz was 2 seconds. The resulting
output consisted of 313 new candidate terms, each consisting of concatenated doublets found in the reference
nomenclature. Human review of the 313 candidate terms yielded a list of 285 terms approved by a curator. A final
automatic extraction of duplicate terms yielded a final list of 222 new terms (71% of the original 313 extracted candidate
terms) that could be added to the reference nomenclature.
Conclusion: The doublet method for automatically extracting candidate nomenclature terms can be used to quickly find
new terms from vast amounts of text. The method can be immediately adapted for virtually any text and any
nomenclature. An implementation of the algorithm, in the Perl programming language, is provided with this article.
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Background
Samuel Johnson defines a lexicographer as a "harmless
drudge" [1]. The drudgery of the lexicographer's tasks is
beyond dispute. In the domain of medical nomenclatures,
however, the harmlessness of the lexicographer is far from
certain. The misuse of medical terminology can lead to
medical errors, as indicated by the U.S. Joint Commission
on Accreditation of Healthcare Organization's recent ban
on certain common medical abbreviations [2]. This action
was taken to reduce the occurrence of medication errors
that result when non-standard abbreviations are misinter-
preted. The U.S. Institute of Medicine has advocated
standardized methods for collecting codified diagnostic
data as a strategy for reducing medical errors [3].
Medical terminologies are replete with examples of minor
term modification that can result in treatment error. One
example is the "carcinoid tumor of appendix." Carcinoid
tumors of the appendix are typically indolent. According
to the U.S. National Cancer Institute, "Surgical resection is
the standard curative modality. If the primary tumor is
localized and resectable, 5-year survival rates are excel-
lent" [4]. There is a variant of appendiceal carcinoid
known as the goblet cell carcinoid of appendix. Someone
uninitiated in tumor biology may infer that the goblet cell
carcinoid is a morphologic variant of an indolent neo-
plasm undeserving of any special designation. Actually,
the goblet cell carcinoid of appendix is a highly malignant
tumor that has a completely different clinical course and
a different recommended treatment than the carcinoid of
appendix [5]. If a neoplasm nomenclature were to omit
the term "goblet cell carcinoid of appendix", someone
encountering the term in a pathology report may mistak-
enly code the subsumed term, "carcinoid of appendix."
Alternately, if the curator of a nomenclature is unaware of
the distinction between the two tumors, he or she may
mistakenly assign the same code to both terms. In either
case, mistaking a carcinoid of the appendix with a goblet
cell carcinoid of appendix could result in harm to the
patient.
Because modern nomenclatures are used to annotate
medical data so that clinical information can be merged
with heterogeneous data sources (e.g. tissue bank records,
research datasets, epidemiologic databases), the duties of
lexicographers have broadened to include a range of infor-
matics activities. For this reason, the modern curator is
involved in codifying terms (providing a unique identifier
to a term and all its synonyms), and mapping terms
between different nomenclatures. In the past, nomencla-
tures were recorded on paper documents. Brevity was
appreciated, and rare lesions may have been neglected.
Modern nomenclatures are stored electronically. With no
barriers to the size of nomenclatures, there is no reason to
exclude any used terms [6].
The purpose of this manuscript is to describe a simple
method for extracting candidate new terms from any large
corpus of text. The method uses the previously published
doublet algorithm to compare connected word doublets
in a medical text against a list of word doublets found in
a nomenclature [7]. Text phrases composed of sequences
of word doublets found in an existing nomenclature are
candidate new nomenclature terms. This general method
can be used with any text and any existing nomenclature.
This method permits curators to continually enhance
their nomenclatures with new terms, an essential activity
needed to ensure the proper coding and annotation of
biomedical data.
Implementation
Nomenclature
As a sample implementation, the developmental lineage
classification and taxonomy of neoplasms, hereinafter
called "the neoplasm taxonomy," was used. The neo-
plasm taxonomy has several properties that make it partic-
ularly suitable:
1. It is a free, open-access medical nomenclature.
2. It has been described in two prior open access publica-
tions [6,8]
3. New versions of the nomenclature are made available
for public download by the Association for Pathology
Informatics [9].
4. It is an easily parsed XML document, with every term
appearing as a lower-case alphanumeric phrase.
5. It is intended to be a comprehensive listing of all items
in a knowledge domain [i.e., names of neoplasms]
The XML version of the neoplasm taxonomy file is
neocl.xml [see Additional file 1]. In this manuscript, the
purpose of the taxonomy is to provide a listing of all
names of neoplasms, with synonyms grouped under a
common code number. The current version of the neo-
plasm taxonomy contains 149,192 unique names of neo-
plasms. In constructing the taxonomy, enormous effort
was made to list every variant name for every known neo-
plasm of man. Variant names included different terms for
the same concept and different ways of expressing an indi-
vidual term (e.g. variations in word order).
Input file
The input file was created by a PubMed query on "am j
surg pathol [jo]", at the U.S. government website [10]. The
query gathered all abstracts from the PubMed database
that were published in the journal "American Journal of
Surgical Pathology." The American Journal of SurgicalBMC Medical Informatics and Decision Making 2005, 5:35 http://www.biomedcentral.com/1472-6947/5/35
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Pathology is a popular repository for articles written to
describing newly encountered neoplasms or distinctive
variants of known neoplasms. The PubMed search pro-
duced 4,289 articles. These were downloaded to an exter-
nal file using PubMed XML (i.e. by selecting "XML" from
PubMed's "Display" list). The downloaded file has a
length of over 31 Megabytes. Each of the 4,289 entries in
the downloaded file contains metadata-tagged fields that
include the PubMed identifier, the title of the article, the
names of the authors, the text of the abstract, and other
citation-related information. Titles of medical articles are
terse summary statements that often contain the names of
disease entities discussed within the article. Although this
file is not included with this manuscript, anyone in the
world with internet access can obtain a near-identical file
by repeating the same PubMed query.
Algorithms
The doublet method was described in a recent publication
[7]. Its utility is derived in part from the observation that
most medical terms are multi-word terms. In the neo-
plasm taxonomy, all but about 250 terms are multi-word
terms. Unlike single words, which often have several dif-
ferent meanings, multi-word medical terms, with very rare
exceptions, have a single, specific meaning.
Any multiword term can be constructed by a concatena-
tion of overlapping doublets.
For example:
Serous borderline ovarian tumor -> ("serous borderline,"
"borderline ovarian," "ovarian tumor")
The doublets composing the multiword terms from a
nomenclature can be combined into a list . The list of
nomenclature doublets can be used to determine whether
a fragment of text is composed from doublets included in
the list.
Algorithm 1
The following algorithm determines those terms present
in a nomenclature that are composed of doublets found
in other terms within the nomenclature.
1. Collect all the doublets that occur in the entire nomen-
clature (i.e., accumulate a list of the doublets from every
term in the nomenclature).
2. Number the occurrences of these doublets (i.e., count
the number of times each doublet occurs anywhere in the
nomenclature)
3. Advance through the nomenclature, term by term,
decomposing the term into its doublets.
4. For each of the doublets that compose a term, retrieve
the total number of occurrences of the doublet in the
nomenclature.
5. Each doublet occurring in a term that has an occurrence
number of 1 is unique to that term and indicates that the
term is not composed entirely of doublets found in other
terms in the nomenclature.
Algorithm 2
The following algorithm parses through text, extracting
candidate term phrases:
1. Collect all the doublets that occur in the entire nomen-
clature (i.e., accumulate a list of the doublets from every
term in the nomenclature).
2. Parse text (in this case individual abstract titles) into an
ordered array of overlapping doublets (as per the example
shown for the text string, "serous borderline ovarian
tumor").
3. Compare each consecutive text doublet against the
array of doublets from the nomenclature to determine
whether the doublet exists somewhere in the nomencla-
ture.
4. If the doublet from the text does not exist in the nomen-
clature, it can be deleted. If it exists in the nomenclature,
it is concatenated with the following doublet if the follow-
ing doublet exists in the nomenclature. Otherwise, it is
deleted. This process continues, concatenating doublets
that exist somewhere in the nomenclature. Extraneous
leading words (the, in, of, with, and) and trailer words,
(the, and, with, from, a) are automatically deleted from
the final concatenated sequence. Final concatenated
sequences of two or greater consecutive doublets that
match to doublets from the nomenclature are saved as
candidate terms.
Software
1. Programming Language
All code was written in Perl. Perl is an open source lan-
guage that is bundled with the Unix and Linux operating
systems. In the past decade, Perl has become very popular
in the bioinformatics community. Perl interpreters are
available at no cost and in versions suitable for virtually
all operating systems. Perl can be obtained from the Com-
prehensive Perl Archives Network [11] or from Active
State [12].
2. The Perl script doubuniq.pl implements algorithm 1 to
locate terms in the nomenclature that contain any
uniquely occurring doublets (i.e., terms that are not exclu-
sively composed of doublets found in other terms fromBMC Medical Informatics and Decision Making 2005, 5:35 http://www.biomedcentral.com/1472-6947/5/35
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the same nomenclature) [see Additional file 2]. Only the
classified terms of the nomenclature (a total of 126,756
terms) were used in this exercise to avoid formatting
inconsistencies present in terms that are pending classifi-
cation. The output of the Perl script is included as a sup-
plemental file [see Additional file 3].
3. The Perl script getdoub.pl implements algorithm 2 to
extract phrases from the text corpora composed of
sequences of doublets included in the original nomencla-
ture and exceeding 4 words in length [see Additional file
4]. The output file is tumoram.out [see Additional file 5].
Results
Analysis of doublet occurrences within terms included in 
the nomenclature
The current version of the neoplasm nomenclature con-
tains 149,192 unique terms. Of these terms 126,756 terms
are classified terms and are composed of at least two
words (i.e., are doublets or greater in length). Of these
126,756 terms, all but 6,308 (4.97%) are composed
entirely of doublets extracted from other terms in the ref-
erence nomenclature. This means that 95% of the classi-
fied terms from the nomenclature are formed entirely of
doublet terms found in other terms from the same
nomenclature. The Perl script and the output text are
included as supplemental files [see Additional file 2] [see
Additional file 3].
Implementation of the candidate term extractor
The Perl script, getdoub.pl was run on a CPU with a proc-
essor speed of 2.79 GHz. The parsed corpus was a PubMed
file in XML format that exceeded 31 Megabytes in length
and contained 4,289 PubMed records. Each record con-
tained an abstract title enclosed by a tag, <ArticleTitle>.
The parser extracted the abstract titles demarcated by the
XML tag, dropped all characters to lower-case, deleted all
characters other than alphanumerics, spaces and hyphens,
deleted the possessive suffix characterized by "'s" and con-
verted plural words to singular words if the word ended in
the suffix "oma" or consisted of the word "tumors" or
"tumours". The total number of words contained in the
4,289 abstract titles was 50,547, and the total number of
characters contained in the 4,289 abstract titles was
395,396. The total execution time to extract a list of can-
didate terms from the corpus was 2 seconds.
Output file of candidate phrases
The output file produced by getdoub.pl is tumoram.out. It
contains 313 candidate phrases each phrase followed by a
copy of the original text from which the candidate term
was extracted. The output is included as a supplemental
file [see Additional file 5]. Each extracted candidate term
consisted entirely of concatenated doublets found within
the reference nomenclature.
In some cases, terms consisting of concatenated doublets
were obviously not names of neoplasms, and a human
expert in the knowledge domain would be needed to dis-
tinguish a real name of a neoplasm from a series of words
that have no particular significance.
The curator read through all 313 phrases, looking for
phrases that suggest a new concept. In this case, the cura-
tor looked for names of neoplasms. This step can only be
performed by a domain expert. Because the exact candi-
date phrases are found in PubMed abstract titles, curators
can obtain additional information on any candidate
phrase by inserting the phrase into the PubMed query box
[10]. In some cases, in-depth review of the literature con-
taining the candidate phrase may suggest a slightly modi-
fied preferred term as a new entry to the nomenclature,
but for the purposes of this manuscript, candidate phrases
were not expanded or embellished with alternate words.
As example, consider line 100 from the output file [see
Additional file 5]. The candidate term is: "synovial sar-
coma of the prostate with t." This term is composed of the
doublets, "synovial sarcoma", "sarcoma of", "of the", "the
prostate", "prostate with", "with t". The full abstract title
from which the term was extracted was: "SYNOVIAL SAR-
COMA OF THE PROSTATE WITH
T(X;18)(P11.2;Q11.2)." The chromosomal marker desig-
nated in the abstract title is not picked up by the extracting
Perl script because (X;18) is not part of a word doublet.
For the purposes of this manuscript, the curator is only
permitted to remove words from the beginning and end
of the candidate phrase (not embellish the phrase). The
curator shortens the term to "synovial sarcoma of the
prostate". If that term is not included in the existing
nomenclature, it can be added to the final list of new
terms. In practice, a curator might wish to add two new
terms to the nomenclature, "synovial sarcoma of the pros-
tate" and "synovial sarcoma of the prostate with T(X;18)
(P11.2;Q11.2)."
Final list of new terms
The output file, tumoram.out contained 313 candidate
terms [see Additional file 5]. Of these 313 terms, a human
curator found 285 terms that represented names of neo-
plasms. These 285 terms were automatically evaluated to
eliminate terms that were duplicated in the reference
nomenclature or on duplicate lines from the output file.
The final list of 222 new terms is shown here:
"acinic cell carcinoma of the lung, adenocarcinoma and
large cell carcinoma of lung, adenomatous hyperplasia of
the rete testis, adenosarcoma of the renal pelvis with het-
erologous elements, adenosarcoma of the uterus with sar-
comatous overgrowth, adrenal cortical adenoma in the
spinal canal, aggressive digital papillary adenoma andBMC Medical Informatics and Decision Making 2005, 5:35 http://www.biomedcentral.com/1472-6947/5/35
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adenocarcinoma, anaplastic carcinoma of the lung, atypi-
cal burkitt lymphoma arising from follicular lymphoma,
atypical duct hyperplasia of the breast, atypical fibrous
histiocytoma of the skin, atypical polypoid adenomyoma
of the uterus, b-cell lymphoma of mucosa-associated lym-
phoid tissue, benign cystic mesothelioma of the liver,
benign epithelioid peripheral nerve sheath tumor of the
soft tissues, benign mesenchymal tumor of lymph node,
benign mesenchymal tumor of the uterus, benign
schwannoma of the digestive tract, bile duct adenoma
clear cell type, bizarre parosteal osteochondromatous pro-
liferation of bone, borderline epithelial lesions of the
breast, borderline papillary serous tumour of the fallopian
tube, botryoid rhabdomyosarcoma of the biliary tract,
breast tumor resembling the tall cell variant of papillary
thyroid carcinoma, carcinoid tumor of the extrahepatic
bile ducts, carcinosarcoma of the female genital tract, clear
cell carcinoma of the gallbladder, clear cell carcinoma of
the ovary, clear cell carcinoma of the skin, clear cell myo-
melanocytic tumor of the thigh, clear cell myomelano-
cytic tumor of the urinary bladder, clear cell sarcoma of
soft tissues, clear cell sarcoma of the ileum, clear cell sugar
tumor of the pancreas, clear cell tumor in the liver, clear
cell tumor of the kidney, clear cell tumor of the lung, com-
bined small cell and spindle cell carcinoma of the lung,
composite follicular variant of papillary carcinoma and
mucoepidermoid carcinoma of the thyroid, condylomata
acuminata of the urinary bladder, congenital cystic adeno-
matoid malformation of the lung, cutaneous epidermo-
tropic alveolar rhabdomyosarcoma, cutaneous follicle
center b-cell lymphoma, cystadenofibroma of the ovary
with epithelial atypia, cystic hamartoma of the renal pel-
vis, desmoplastic small cell tumor in the pancreas, desmo-
plastic small cell tumor of soft tissues, desmoplastic small
round cell tumor of the pleura, diffuse mesothelioma of
the genital tract and peritoneum, ductal adenoma of the
breast, ductal carcinoma in situ in breast, ductal carci-
noma in situ in salivary duct carcinoma, ductal carcinoma
in situ of the female breast, dysplasia of the epididymis,
endometrial stromal and smooth muscle tumor of the
uterus, epithelial mesothelioma of the pleura, epithelial-
stromal tumor of the seminal vesicle, epithelioid heman-
gioendothelioma of skin and soft tissues, epithelioid leio-
myosarcoma of the skin and subcutaneous tissue,
epithelioid mesothelioma of the pleura, ewing family of
tumor, extragastrointestinal stromal tumor gastrointesti-
nal stromal tumor of the soft tissue, extramammary paget
disease of the oral mucosa, familial adenomatous polypo-
sis associated with multiple endocrine neoplasia, foamy
gland high-grade prostatic intraepithelial neoplasia, folli-
cle center lymphoma of the ampulla of vater, follicular
center-cell lymphoma with plasmacytic differentiation,
follicular dendritic cell tumor of the liver, follicular den-
dritic cell tumor of the oral cavity, follicular thyroid carci-
noma with clear cell change, gastric mucosa-associated
lymphoid tissue, gastric neuroendocrine tumor in multi-
ple endocrine neoplasia, gastrointestinal autonomic nerve
tumor in the colon, germ cell neoplasms of the testis,
giant cell tumor of soft tissues, glycogen-rich clear cell car-
cinoma of the breast, granular cell tumor of the lung,
granulocytic sarcoma of the female genital tract, hemat-
opoietic tumor in chronic myeloproliferative disorders,
high-grade dysplasia in a colonic adenoma, histiocytic
lymphoma of the central nervous system, histiocytic sar-
coma involving the central nervous system, hyalinizing
trabecular adenoma and papillary carcinoma of the thy-
roid gland, hyalinizing trabecular tumor of the thyroid
gland, hyperplasia of interstitial cells of cajal, infiltrating
colloid carcinoma of the pancreas, inflammatory fibroid
polyp of the stomach, intestinal metaplasia of the distal
esophagus, intraductal carcinoma of the oral cavity, juve-
nile granulosa cell tumor of the ovary, keratinizing squa-
mous cell cancer of the cervix, langerhans cell
granulomatosis of the thymus, large cell lymphoma of the
mediastinum, lobular carcinoma in situ of the female
breast, low grade b-cell lymphoma of mucosa associated
lymphoid tissue, low malignant potential tumor of the
ovary, low-grade b-cell lymphoma of mucosa-associated
lymphoid tissue, low-grade endometrial stromal sarcoma,
lymphoid hyperplasia of the gastrointestinal tract, lym-
phoma of the gastrointestinal tract, malignant epithelioid
hemangioendothelioma of the liver, malignant epithe-
lioid schwannoma, malignant fibrous histiocytoma of the
extremities, malignant fibrous tumor of the pleura, malig-
nant giant cell tumor of the tendon sheaths, malignant
lymphoma of the mucosa-associated lymphoid tissue,
malignant lymphoma of the small bowel, malignant lym-
phoma of the upper aerodigestive tract, malignant
melanoma of the esophagus, malignant melanoma of the
urethra, malignant mesonephric tumor of the female gen-
ital tract, malignant mesothelioma of the tunica vaginalis,
malignant neuroendocrine tumor of the jejunum with
osteoclast-like giant cells, malignant ovarian tumor with
osteoclast-like giant cells, malignant peripheral nerve
sheath tumor of infancy, malignant small cell tumor of
thoracopulmonary region, marginal zone b-cell lym-
phoma in children and young adults, marginal zone b-cell
lymphoma of the salivary gland arising in chronic sclero-
sing sialadenitis, melanocytic neoplasms of the central
nervous, metaplasia of the renal collecting ducts, microin-
vasive squamous carcinoma of the esophagus, micropap-
illary variant of transitional cell carcinoma of the urinary
bladder, mixed endometrial stromal and smooth muscle
tumor of the uterus, mucin-secreting adenocarcinoma of
the prostate with neuroendocrine differentiation, muci-
nous adenocarcinoma of the prostate gland, mucinous
borderline tumor of the ovary mucinous cystic tumor of
the ovary, multiple lymphomatous polyposis of the gas-
trointestinal tract, myoepithelial carcinoma of the salivary
glands, neuroendocrine merkel cell carcinoma, nonsmallBMC Medical Informatics and Decision Making 2005, 5:35 http://www.biomedcentral.com/1472-6947/5/35
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cell carcinoma of the lung, oat cell carcinoma of the kid-
ney, oncocytic mucoepidermoid carcinoma of the salivary
glands, ovarian sertoli cell tumor with retiform and heter-
ologous elements, papillary carcinoma of the bladder,
papillary cystic tumor of the pancreas, papillary transi-
tional cell carcinoma of the renal pelvis, papillary urothe-
lial neoplasms of low malignant potential, pediatric soft
tissue tumor, peripheral nerve sheath tumor of the adre-
nal, peritoneal serous micropapillomatosis of low malig-
nant potential serous borderline tumor of the
peritoneum, perivascular epithelioid clear cell family of
tumor, peutz-jeghers syndrome with adenoma and aden-
ocarcinoma, plasma cell granuloma of the lung, plasmab-
lastic lymphoma of the oral cavity, pleomorphic adenoma
mixed tumor of the major salivary glands, pleomorphic
hyalinizing angiectatic tumor of soft parts, pleomorphic
large cell lymphoma of the mediastinum, pleomorphic
soft tissue myogenic sarcoma of adulthood, polycystic
adenosis of major salivary glands, precursor of uterine
papillary serous carcinoma, primary embryonal rhab-
domyosarcoma of long bone, primary hepatic non-hodg-
kin lymphoma in childhood, primary lung carcinoma
with signet-ring cell carcinoma, primary lymphoma of the
small intestine, primary malignant lymphoma of the
cauda equina, primary malignant melanoma of the ante-
rior mediastinum, primary mixed adenocarcinoma and
small cell carcinoma of the appendix, primary mucinous
carcinoma of the skin, primary mucinous tumor of the
ovary, primary neuroendocrine merkel cell carcinoma of
the skin, primary ovarian small cell carcinoma, primary
ovarian squamous cell carcinoma, primary squamous cell
carcinoma of the ovary, primary synovial sarcoma of the
kidney, primary tumor of the exocrine pancreas, pulmo-
nary carcinoma with pleomorphic sarcomatoid or sarco-
matous elements, pulmonary malignant lymphoma of
mucosa-associated lymphoid tissue, reactive lymphoid
hyperplasia of the spleen, renal angiomyolipoma with
epithelioid sarcomatous transformation, renal cell carci-
noma in children and young adults, renal cell carcinoma
in tuberous sclerosis, reticulum cell neoplasms of lymph
nodes, rhabdoid tumor of the gastrointestinal tract, round
cell tumor of the tibia, sclerosing mucoepidermoid thy-
roid carcinoma with eosinophilia, serous borderline
tumor of the peritoneum, serous borderline tumor of the
peritoneum, signet-ring cell lymphoma of t-cell origin,
small cell anaplastic carcinoma of the lung, small cell
sweat gland carcinoma, small cell sweat gland carcinoma
in childhood, small cell tumor of the lung, small cleaved
cell lymphoma in bone marrow, small lymphocytic lym-
phoma leukemia, smooth muscle tumor of the gastroin-
testinal tract, smooth muscle tumor of the liver, smooth
muscle tumor of the ovary, soft tissue lymphoma of the
extremities, solid and cystic papillary epithelial neoplasm
of the pancreas, solitary fibrous tumor of soft tissue, soli-
tary fibrous tumor of the kidney, solitary fibrous tumor of
the liver, solitary fibrous tumor of the mediastinum, soli-
tary fibrous tumor of the nasal cavity, solitary fibrous
tumor of the orbit, solitary fibrous tumor of the spinal
cord, solitary fibrous tumor of the thyroid gland, solitary
fibrous tumor of the upper respiratory tract, spindle cell
and epithelioid cell nevi with atypia, spindle cell neo-
plasms of lymph nodes, spindle cell tumor of the pleura,
spindle-cell carcinoid tumor of the lung, spindle-cell car-
cinoma of the upper aerodigestive tract, squamous cell
carcinoma of the palatine tonsil, squamous cell carci-
noma of the upper aerodigestive tract, stromal neoplasms
of the gastrointestinal tract, systemic mast cell disease
involving the bone marrow, t-cell histiocyte-rich large b-
cell lymphoma of the spleen, t-cell lymphoma in the
small intestine, t-cell-rich b-cell lymphoma of the spleen,
thymic squamous cell carcinoma associated with mixed
type thymoma, transitional cell carcinoma with rhabdoid
features, transitional cell metaplasia of the uterine cervix,
transitional cell tumor of the pituitary, urothelial carci-
noma of the renal pelvis, urothelial transitional cell neo-
plasms of the urinary bladder, variant of malignant
peripheral nerve sheath tumor, vascular hamartoma of the
small bowel, well-differentiated neuroendocrine tumor,
well-differentiated papillary mesothelioma of the pleura,
yolk sac tumor of the anterior mediastinum."
Examination of the terms indicates that the majority of
terms are either very rare and obscure tumors, unusual
variants of common tumors, or just unusual terms for
common and uncommon tumors. Pathologists reading
this list may agree that the tumors from this list include
clinically distinct and significant subclasses of tumors and
would be welcome additions to a truly comprehensive
nomenclature of neoplastic entities.
Discussion
Adding terms to an existing vocabulary is best done by
reading the current literature in the knowledge domain of
the nomenclature, and transcribing new terms when they
are encountered. It is difficult to imagine any automatic
process that can replace this scholarly pursuit. Terms
encountered while reading a scientific text appear in a
structured context that often defines the term, clarifies the
relationship of the new term to related terms, and some-
times provides sufficient information to classify the new
term within a structured taxonomic hierarchy.
Sadly, it is impossible for curators to read all of the bio-
medical literature pertaining to a nomenclature's domain.
The purpose of the doublet phrase extractor is to parse
through any corpus of text, extracting phrases that may
contain new nomenclature terms. The phrases are chosen
to meet two criteria: 1) they are composed of word dou-
blets that are contained in an existing nomenclature, and
2) the matched phrases do not already occur in theBMC Medical Informatics and Decision Making 2005, 5:35 http://www.biomedcentral.com/1472-6947/5/35
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nomenclature. The doublet extractor works fast to pro-
duce a neat list of candidate phrases that can be conven-
iently reviewed by a curator. In the case described herein,
a 31+ MByte corpus was extracted in 2 seconds, to produce
313 candidate phrases. From the candidate phrases, the
curator found 222 phrases that could be added to the ref-
erence nomenclature (30 minutes of human effort).
Because the final term list was extracted from PubMed
abstract titles, the contained terms have two important
properties:
1. The terms have whatever legitimacy publication con-
fers. Nobody can say that the extracted terms are confabu-
lated or never actually used.
2. The terms can be searched and found through a
PubMed search. The articles that contain the terms are
likely to describe or define the terms.
Limitations of the output
New terms that are not composed of doublets found in
pre-existing nomenclature terms will be missed by the
doublet extraction method. This would certainly apply to
most new eponymous terms, new terms extracted from a
foreign language, new terms using variant orthography, or
newly invented words (e.g. theragnostics, glycomics,
nanoscope). In the realm of neoplasms, it would be diffi-
cult to create a new term that is not partially composed of
older terms.
If the extraction software used a vocabulary that already
contained every term in the knowledge domain, then
there would be very few candidate terms extracted
(because parsed terms already included in the nomencla-
ture are immediately rejected). In addition, any candidate
terms extracted from the corpus would always be rejected
by the human curator (0% precision). This is because the
nomenclature would be complete, and any candidate
terms must be false terms.
If the extraction software used a text corpus that consisted
exclusively of valid, new nomenclature terms that should
be added to an incomplete vocabulary, then all of the
extracted candidate terms would be valid new terms
(100% precision). If the extraction used a text that con-
tained no valid terms from the knowledge domain, then
every extracted candidate term would be an invalid term
(0% precision).
This is a problem: the effectiveness of the software is
dependent on the completeness of the source vocabulary
and on the presence of valid new terms existing in the text
corpus. In addition, the suitability of candidate terms for
inclusion in the vocabulary will ultimately depend on
subjective decisions reached by the human curator.
For this manuscript, the author chose to include the
extractor's output as a supplemental file [see Additional
file 5], so that interested readers can form their own judg-
ments regarding the value of the software. In addition, the
availability of a public set of files (software implementa-
tion, nomenclature and text corpus) will facilitate future
efforts to compare improved versions of the extraction
algorithm with this first version.
Characteristics of the approach
Recently, Krauthammer and Nenadic reviewed methods
for identifying nomenclature terms within text [14]. In all
cases, the reviewed methods were evaluated based on
published measurements of precision and recall. There
was no common procedure for determining how the text
would be manually coded. Manually coded text is used to
measure the precision and recall, and if the rules for man-
ual coding differ from study to study, so would the pub-
lished performance measurements [15]. The speed of the
different methods was not compared, and there was no
common text corpus or nomenclature for the different
studies. Most of the discussed methods were published in
the Proceedings of various data mining workshops, and
the source code, source vocabularies, and output files
were not made available to the public. Because the source
code for most of these methods is not accessible, it is dif-
ficult to determine the degree in which the methodology
is vocabulary-dependent and whether the methods have
generalized utility. For these reasons, it is impossible to
state whether the doublet method is superior to previ-
ously published methods [16-19].
It is the perception of the author that the field of medical
informatics suffers from a lack of simple and generalized
methods that can be easily tested in various use cases or
compared with alternate or new methods using shared
corpora. In their review of methods for automatically
identifying medical terms contained in text, Krauthammer
and Nenadic commented that few terminologically tagged
biomedical corpora are available [14], and this makes it
impossible to compare different informatics methods.
This manuscript describes a method for extracting candi-
date terms from a corpus of text. It uses the doublet
method previously described [7]. The doublet method has
similarities to data retrieval techniques using bi-grams
and word-pairs [20]. The method is fast, convenient, and
suits the purposes of the author, who curates the neo-
plasm taxonomy. The method requires substantial human
involvement to winnow down the list of candidate terms
into a final collection of well-formed new nomenclature
terms. The methodology has the following features:BMC Medical Informatics and Decision Making 2005, 5:35 http://www.biomedcentral.com/1472-6947/5/35
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1. The method will work with any nomenclature and with
any plain-text file
2. The implementation is provided with the details of
operation, allowing others to repeat the study.
3. The source code is platform-independent and is made
freely available to the public. This permits other laborato-
ries to modify the program and publish an improved ver-
sion of this documented prototype.
4. The output files are provided, permitting others to
review the results from this study or to compare the results
with the results obtained with other methods.
Conclusion
Almost all terms in medical nomenclatures can be formed
by combining word doublets derived from other terms in
the same nomenclature. By collecting all the word dou-
blets found in a nomenclature, it is possible to quickly
parse through enormous tracts of text, extracting phrases
composed of sequences of these doublets. From these
extracted candidate terms, a curator can select new terms.
The doublet method is a novel approach to term extrac-
tion that curators can use to augment medical nomencla-
tures.
Availability and requirements
The provided supplementary scripts are short programs
written in Perl. Perl is a freely available open source pro-
gramming language. Perl interpreters for virtually any
operating system are available from several sites on the
web [11,12]. These sites have links to rich sources of
online information on the Perl language. The scripts
require an external file of PubMed XML text. The scripts
can be easily modified to accept any plain-text external
file. The scripts require the neoplasm taxonomy [see Addi-
tional file 1], but can be modified to accept any parsable
nomenclature that contains listed plain-text terms.
The Perl scripts provided with this manuscript will work
without modification using the current version of the neo-
plasm taxonomy [see Additional file 1]. New versions of
the neoplasm taxonomy are posted at the Association for
Pathology Informatics website [9].
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